Press Release Summary:
Offered as modular andÂ upgradeable platform, Ultima Series™ is capable of performing pulmonary function and metabolic testing. Cardiorespiratory diagnostic system, designed with patient and operator in mind, allows for flexibility and operational efficiency, facilitating patient care.
Original Press Release:
MGC Diagnostics Corporation Announces Newly Repackaged Ultima Series(TM)
SAINT PAUL, Minn. -- MGC Diagnostics Corporation (NASDAQ: MGCD), a global medical technology leader, announced today the release of its latest design of the Ultima Series( TM) cardiorespiratory diagnostic system, capable of performing both pulmonary function and metabolic testing in a single, modular, upgradeable platform, utilizing the latest technology. The system will be featured at the upcoming American Thoracic Society Meeting along with the full MGC Diagnostics Medical Graphics product line. Todd M. Austin, CEO of MGC Diagnostics, commented "This generation of MGC Diagnostic's Ultima Series( TM), designed with both the patient and operator in mind, allows for maximum flexibility and operational efficiency, making it even easier to deliver cardiorespiratory diagnostic patient care with our intuitive, easy-to-use technology."
For more information about MGC Diagnostic's products, including the Ultima Series, please visit http://mgcdiagnostics.com/products.
About MGC Diagnostics
MGC Diagnostics Corporation (NasdaqCM: MGCD) is a global medical technology company dedicated to cardiorespiratory health solutions. The Company, through its Medical Graphics Corporation and MediSoft SA subsidiaries, develops, manufactures and markets non-invasive diagnostic systems. This portfolio of products provides solutions for disease detection, integrated care, and wellness across the spectrum of cardiorespiratory healthcare. The Company's products are sold internationally through distributors and in the United States through a direct sales force targeting heart and lung specialists located in hospitals, university-based medical centers, medical clinics, physicians' offices, pharmaceutical companies, medical device manufacturers, and clinical research organizations (CROs). For more information about MGC Diagnostics, visit www.mgcdiagnostics.com.
Wesley W. Winnekins
MGC Diagnostics Corporation
Chief Financial Officer
Joe Dorame, Robert Blum, Joe Diaz
Lytham Partners, LLC